- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NanoInk, parent company of the NanoGuardian, NanoFabrication, NanoProfessor and NanoBioDiscovery Divisions announces a $65 million financing to further expand commercial activities
NanoInk, Inc. ® announced today a $65 million financing led by Lurie Investments.
The financing will be used to convert outstanding debt to equity and to provide working capital to expand commercial activities across the company's nanotechnology business. NanoInk currently markets and sells nine nanotechnology products across four divisions worldwide.
"This financing provides working capital to continue our commercial activities and support our growing sales base," said James M. Hussey, Chief Executive Officer of NanoInk. "This financing also provides an opportunity for the company to convert substantially all of our debt
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop.
Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net.
For more information, please click here
David Gutierrez, Dresner Corporate Services, (312) 780-7204,
Copyright © NanoInkIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016